World Weight Loss Medication Market
Dublin, April 24, 2024 (GLOBE NEWSWIRE) — The “Weight Loss Medication World Market Report 2024” report has been added to ResearchAndMarkets.com’s providing.
The load loss medicine market measurement has grown exponentially in recent times. It should develop from $1.94 billion in 2023 to $2.87 billion in 2024 at a compound annual development price (CAGR) of 47.8%. The expansion noticed within the historic interval could be attributed to a number of elements, together with the growing charges of weight problems, adjustments in way of life, heightened consciousness and schooling about weight-related points, early analysis of medical circumstances, and a normal rise in healthcare expenditure. These elements collectively contributed to a higher demand for weight reduction medicine as people sought options to handle and handle weight-related issues throughout the historic interval.
The load loss medicine market measurement is predicted to see exponential development within the subsequent few years. It should develop to $12.17 billion in 2028 at a compound annual development price (CAGR) of 43.5%. The anticipated development within the forecast interval could be attributed to elements such because the growing geriatric inhabitants, the affect of social media, traits in health and wellness, cultural perceptions of magnificence, and continued investments by the pharmaceutical trade. Key traits anticipated within the forecast interval embrace developments in expertise, a give attention to non-prescription options, the emergence of personalised medication, the exploration of mixture therapies, ongoing product innovation, and an emphasis on post-market surveillance. These traits recommend a dynamic panorama within the weight reduction drug trade, with a give attention to evolving methods and options to fulfill numerous wants and preferences.
The anticipated improve in weight problems charges is predicted to drive the expansion of the burden loss medicine market. In September 2023, the Facilities for Illness Management and Prevention reported that grownup weight problems charges exceeded 35% in 19 states in 2021 and 22 states in 2022, with prevalence at or above 35% in 2022. Moreover, the World Weight problems Federation estimated that over 4 billion individuals are anticipated to be overweight by 2035. The rising weight problems charges are a key driver for the expansion of the burden loss medicine market.
Main corporations within the weight reduction drug market are specializing in the event of progressive merchandise to higher serve sufferers. One such instance is Zepbound (tirzepatide) injection, a once-weekly injectable twin glucose-dependent insulinotropic polypeptide (GIP) and glucagon-such as peptide-1 (GLP-1) receptor agonist. In November 2023, Eli Lilly and Firm, a US-based pharmaceutical firm, acquired FDA approval for tirzepatide injection (Zepbound) for persistent weight administration in adults with chubby or weight problems and a minimum of one weight-related situation. Zepbound stands out as the primary and solely FDA-approved weight problems therapy that prompts each GIP and GLP-1 receptors, displaying potential for industrial success.
In December 2023, Roche Holding AG, a Switzerland-based healthcare firm, efficiently acquired Carmot Therapeutics Inc. for $2.7 billion. This strategic acquisition granted Roche entry to 2 weight problems drug candidates, together with an injectable prepared for part 2 medical trials and a day by day capsule model in part 1 trials. The acquisition aimed to strengthen Roche’s place within the aggressive and rising weight problems drug market. Carmot Therapeutics Inc., a US-based clinical-stage biotechnology firm, specializes within the discovery and growth of disease-modifying therapies for weight problems and diabetes.
North America was the most important area within the Weight Loss Medication market in 2023. The areas lined within the weight reduction medicine market report are Asia-Pacific, Western Europe, Jap Europe, North America, South America, Center East, Africa. The nations lined within the weight reduction medicine market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Scope
Markets Coated:
1) By Sort: Liquid; Tablets; Capsules
2) By Distribution Channel: Hospital Pharmacy; Retail Pharmacy; On-line Pharmacy
3) By Software: Weight-Lowering Assist; Fats Absorption Inhibitors; Metabolic Boosters
Key Firms Talked about: Pfizer Inc.; Roche; Merck & Co.; AbbVie Inc.; Novartis AG
Time Sequence: 5 years historic and ten years forecast.
Information: Ratios of market measurement and development to associated markets, GDP proportions, expenditure per capita.
Information Segmentation: Nation and regional historic and forecast knowledge, market share of rivals, market segments.
Key Attributes
|
Report Attribute |
Particulars |
|
No. of Pages |
175 |
|
Forecast Interval |
2024-2028 |
|
Estimated Market Worth (USD) in 2024 |
$2.87 Billion |
|
Forecasted Market Worth (USD) by 2028 |
$12.17 Billion |
|
Compound Annual Progress Charge |
43.5% |
|
Areas Coated |
World |
A choice of corporations talked about on this report contains, however is just not restricted to:
-
Pfizer Inc.
-
Roche
-
Merck & Co.
-
AbbVie Inc.
-
Novartis AG
-
Bristol Myers Squibb
-
Sanofi S.A.
-
AstraZeneca plc
-
LG Chem
-
GlaxoSmithKline
-
Takeda Pharmaceutical Firm
-
Eli Lilly and Firm
-
Bayer AG
-
Amgen Inc.
-
Boehringer Ingelheim group
-
Novo Nordisk A/S
-
Merck KGaA
-
Teva Pharmaceutical Industries Ltd.
-
Hisun Pharmaceutical
-
Taj Prescribed drugs Ltd
-
Zhongshan Pharmaceutical Co. Ltd.
-
Dm Pharma
-
Lunan Pharmaceutical Group Company
-
Wolfson Berg Ltd.
-
Swiss Analysis Labs Ltd.
For extra details about this report go to https://www.researchandmarkets.com/r/g05u0q
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s main supply for worldwide market analysis studies and market knowledge. We offer you the newest knowledge on worldwide and regional markets, key industries, the highest corporations, new merchandise and the newest traits.
Attachment
CONTACT: CONTACT: ResearchAndMarkets.com Laura Wooden,Senior Press Supervisor [email protected] For E.S.T Workplace Hours Name 1-917-300-0470 For U.S./ CAN Toll Free Name 1-800-526-8630 For GMT Workplace Hours Name +353-1-416-8900
